Buscador de publicacions

Publicacions

  • Sanguino E, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Different response of senescent female Sprague-Dawley rats to gemfibrozil and rosiglitazone administration.

    EXPERIMENTAL GERONTOLOGY . 40(7): 588-598. Nº de cites: 6

    [doi:10.1016/j.exger.2005.05.006]

  • Jové M, Planavila A, Laguna JC and Vazquez M.

    Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells.

    Endocrinology . 146(7): 3087-3095. Nº de cites: 115

    [doi:10.1210/en.2004-1560]

  • Llaverias G, Lacasa D, Vazquez M, Sánchez RM, Laguna JC and Alegret M.

    Cholesterol regulation of genes involved in sterol trafficking in human THP-1 macrophages.

    MOL CELL BIOCHEM . 273(1-2): 185-191. Nº de cites: 14

    [doi:10.1007/s11010-005-0624-8]

  • Jové M, Laguna JC and Vazquez M.

    Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1734(1): 52-61. Nº de cites: 26

    [doi:10.1016/j.bbalip.2005.02.002]

  • Planavila A, Laguna JC and Vazquez M.

    Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.

    JOURNAL OF BIOLOGICAL CHEMISTRY . 280(17): 17464-17471. Nº de cites: 110

    [doi:10.1074/jbc.M414220200]

  • Planavila A, Alegret M, Sánchez RM, Rodríguez-Calvo R, Laguna JC and Vazquez M.

    Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice.

    BIOCHEMICAL PHARMACOLOGY . 69(8): 1195-1204. Nº de cites: 26

    [doi:10.1016/j.bcp.2005.01.015]

  • Viñals M, Bermúdez I, Llaverias G, Alegret M, Sanchez RM, Vazquez M and Laguna JC.

    Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages.

    CARDIOVASCULAR RESEARCH . 66(1): 141-149. Nº de cites: 43

    [doi:10.1016/j.cardiores.2004.12.024]

  • Planavila A, Rodríguez-Calvo R, Jové M, Michalik L, Wahli W, Laguna JC and Vazquez M.

    Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.

    CARDIOVASCULAR RESEARCH . 65(4): 832-841. Nº de cites: 156

    [doi:10.1016/j.cardiores.2004.11.011]

  • Planavila A, Laguna JC and Vazquez M.

    Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1687(1-3): 76-83. Nº de cites: 86

    [doi:10.1016/j.bbalip.2004.11.004]

  • Llaverias G, Vazquez M, Sánchez RM, Noé V, Ciudad CJ, Laguna JC and Alegret M.

    Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism.

    JOURNAL OF LIPID RESEARCH . 45(11): 2015-2024. Nº de cites: 60

    [doi:10.1194/jlr.M400049-JLR200]